Alnylam Pharmace. buy Biotechhunter
Start price
05.05.20
/
50%
€132.36
Target price
13.05.20
-
Performance (%)
-1.84%
End price
13.05.20
€129.92
Summary
This prediction ended on 13.05.20 with a price of €129.92. With a performance of -1.84%, the BUY prediction for Alnylam Pharmace. by Biotechhunter closed slightly in the red. Biotechhunter has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 7.770% | 7.770% | -0.755% | 58.621% |
| iShares Core DAX® | 4.572% | 3.428% | 8.167% | 58.377% |
| iShares Nasdaq 100 | 1.832% | -1.036% | 34.659% | 87.702% |
| iShares Nikkei 225® | -0.289% | 3.380% | 61.852% | 78.201% |
| iShares S&P 500 | 2.229% | 0.472% | 25.073% | 65.682% |
Comments by Biotechhunter for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.